Literature DB >> 26181316

Advanced diffuse malignant peritoneal mesothelioma responding to palliative chemotherapy.

Koji Nakashima1, Haruhiko Inatsu2, Kazuo Kitamura2, Tomomi Hikosaka2, Shinri Hoshiko2, Shinya Ashiduka2.   

Abstract

A 64-year-old man diagnosed with advanced malignant peritoneal mesothelioma by laparoscopic biopsy was treated with systemic chemotherapy. The patient underwent first-line chemotherapy with pemetrexed plus cisplatin for 11 months, then second-line chemotherapy with gemcitabine plus vinorelbine for 6 months, and third-line chemotherapy with CPT-11 for 4 months. After third-line chemotherapy failed, he received palliative treatment. Although the tumor continued to grow, and he died 24 months after initiation of treatment, chemotherapy prolonged the survival time and improved his quality of life.

Entities:  

Keywords:  Chemotherapy; Cisplatin; Diffuse type; Malignant peritoneal mesothelioma; Pemetrexed

Year:  2012        PMID： 26181316     DOI： 10.1007/s12328-012-0334-1

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN： 1865-7265


  15 in total

Review 1.  A review of peritoneal mesothelioma at the Washington Cancer Institute.

Authors:  Paul H Sugarbaker; Laura S Welch; Faheez Mohamed; Olivier Glehen
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

Review 2.  Current concepts: malignant mesothelioma.

Authors:  K H Antman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

3.  Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.

Authors:  Pasi A Jänne; Anoinette J Wozniak; Chandra P Belani; Mary-Louise Keohan; Helen J Ross; Jonathan A Polikoff; David M Mintzer; Loretta Taylor; Joseph Ashland; Zhishen Ye; Matthew J Monberg; Coleman K Obasaju
Journal:  Clin Lung Cancer       Date:  2005-07       Impact factor: 4.785

4.  Clinical presentation and natural history of benign and malignant mesothelioma.

Authors:  K H Antman
Journal:  Semin Oncol       Date:  1981-09       Impact factor: 4.929

5.  Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma.

Authors:  C Manegold; J Symanowski; U Gatzemeier; M Reck; J von Pawel; C Kortsik; K Nackaerts; P Lianes; N J Vogelzang
Journal:  Ann Oncol       Date:  2005-04-11       Impact factor: 32.976

6.  Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

Authors:  Paolo A Zucali; Giovanni L Ceresoli; Isabella Garassino; Fabio De Vincenzo; Raffaele Cavina; Elisabetta Campagnoli; Federico Cappuzzo; Silvia Salamina; Hector J Soto Parra; Armando Santoro
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

7.  Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM).

Authors:  B Castagneto; M Botta; E Aitini; F Spigno; D Degiovanni; O Alabiso; M Serra; A Muzio; R Carbone; R Buosi; V Galbusera; E Piccolini; L Giaretto; L Rebella; M Mencoboni
Journal:  Ann Oncol       Date:  2007-12-20       Impact factor: 32.976

8.  Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent.

Authors:  G Carteni; C Manegold; G Martin Garcia; S Siena; C C Zielinski; D Amadori; Y Liu; J Blatter; C Visseren-Grul; R Stahel
Journal:  Lung Cancer       Date:  2008-11-29       Impact factor: 5.705

9.  Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.

Authors:  Giovanni L Ceresoli; Paolo A Zucali; Adolfo G Favaretto; Francesco Grossi; Paolo Bidoli; Guido Del Conte; Anna Ceribelli; Alessandra Bearz; Emanuela Morenghi; Raffaele Cavina; Maurizio Marangolo; Hector J Soto Parra; Armando Santoro
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

10.  Malignant abdominal mesothelioma: defining the role of surgery.

Authors:  Dayron Rodríguez; Michael C Cheung; Nadine Housri; Leonidas G Koniaris
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454
View more
  1 in total

1.  A case of malignant peritoneal mesothelioma suggesting the utility of combining double-contrast radiography and endoscopy with computed tomography for diagnosis.

Authors:  Hirokazu Saito; Shota Hasuda; Jiro Nasu; Mitsuhiko Kitaoka; Ikuo Matsushita
Journal:  Clin J Gastroenterol       Date:  2017-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.